These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
83 related articles for article (PubMed ID: 18398144)
1. Perioperative risks of bevacizumab and other biologic agents for hepatectomy: theoretical or evidence based? Bilchik AJ; Hecht JR J Clin Oncol; 2008 Apr; 26(11):1786-8. PubMed ID: 18398144 [No Abstract] [Full Text] [Related]
2. Lack of evidence for increased operative morbidity after hepatectomy with perioperative use of bevacizumab: a matched case-control study. D'Angelica M; Kornprat P; Gonen M; Chung KY; Jarnagin WR; DeMatteo RP; Fong Y; Kemeny N; Blumgart LH; Saltz LB Ann Surg Oncol; 2007 Feb; 14(2):759-65. PubMed ID: 17103075 [TBL] [Abstract][Full Text] [Related]
3. In search of the black sheep: is it bevacizumab or extended chemotherapy? Vauthey JN; Zorzi D Ann Surg Oncol; 2009 Jun; 16(6):1463-4. PubMed ID: 19357926 [No Abstract] [Full Text] [Related]
4. Volumetric analysis of remnant liver regeneration after major hepatectomy in bevacizumab-treated patients: a case-matched study in 82 patients. Millet G; Truant S; Leteurtre E; Hebbar M; Zerbib P; Huet G; Boleslawski E; Pruvot FR Ann Surg; 2012 Nov; 256(5):755-61; discussion 761-2. PubMed ID: 23095619 [TBL] [Abstract][Full Text] [Related]
5. Preoperative liver hypertrophy induced by portal flow occlusion before major hepatic resection for colorectal metastases can be impaired by bevacizumab. Aussilhou B; Dokmak S; Faivre S; Paradis V; Vilgrain V; Belghiti J Ann Surg Oncol; 2009 Jun; 16(6):1553-9. PubMed ID: 19363584 [TBL] [Abstract][Full Text] [Related]
6. Surgical resection after downsizing of colorectal liver metastasis in the era of bevacizumab. Ellis LM; Curley SA; Grothey A J Clin Oncol; 2005 Aug; 23(22):4853-5. PubMed ID: 16051943 [No Abstract] [Full Text] [Related]
8. Bevacizumab and postoperative complications after hepatic surgery for colorectal metastases. Petrelli NJ J Clin Oncol; 2009 Apr; 27(11):1917; author reply 1918. PubMed ID: 19255304 [No Abstract] [Full Text] [Related]
9. [Roles of hepatectomy for colorectal liver metastases with necrotic foci caused by prior anti-cancer therapies]. Ko S; Mukogawa T; Ishikawa H; Inoue T; Nishiwada T; Nakamoto T; Kunishige T; Watanabe A Gan To Kagaku Ryoho; 2010 Nov; 37(12):2569-72. PubMed ID: 21224642 [TBL] [Abstract][Full Text] [Related]
10. Liver resection for metastatic colorectal cancer in the age of neoadjuvant chemotherapy and bevacizumab. Yoo PS; Lopez-Soler RI; Longo WE; Cha CH Clin Colorectal Cancer; 2006 Sep; 6(3):202-7. PubMed ID: 17026789 [TBL] [Abstract][Full Text] [Related]
11. Biologic modulation of chemotherapy in patients with hepatic colorectal metastases: the role of anti-VEGF and anti-EGFR antibodies. Geva R; Prenen H; Topal B; Aerts R; Vannoote J; Van Cutsem E J Surg Oncol; 2010 Dec; 102(8):937-45. PubMed ID: 21165996 [TBL] [Abstract][Full Text] [Related]
12. Reply to Y. Sunakawa et al and P. Mroczkowski et al. Ye LC; Zhong YS; Lin Q; Xu J J Clin Oncol; 2013 Dec; 31(35):4474-5. PubMed ID: 24166525 [No Abstract] [Full Text] [Related]
13. Treatment of metastatic colorectal cancer with monoclonal antibody to vascular endothelial growth factor: does the metastatic site make the difference? Graziano F; Cascinu S J Clin Oncol; 2003 Sep; 21(18):3542-3; author reply 3543. PubMed ID: 12972535 [No Abstract] [Full Text] [Related]
14. Role of adjuvant therapy after resection of colorectal cancer liver metastases. Power DG; Kemeny NE J Clin Oncol; 2010 May; 28(13):2300-9. PubMed ID: 20368552 [TBL] [Abstract][Full Text] [Related]
15. First- and second-line therapy of metastatic colorectal cancer. Terstriep S; Grothey A Expert Rev Anticancer Ther; 2006 Jun; 6(6):921-30. PubMed ID: 16761936 [TBL] [Abstract][Full Text] [Related]
16. Infarct-like necrosis: a distinct form of necrosis seen in colorectal carcinoma liver metastases treated with perioperative chemotherapy. Chang HH; Leeper WR; Chan G; Quan D; Driman DK Am J Surg Pathol; 2012 Apr; 36(4):570-6. PubMed ID: 22301494 [TBL] [Abstract][Full Text] [Related]
17. Control arm for surgery alone is needed but difficult to obtain in randomized trials for adjuvant chemotherapy after liver resection for colorectal metastases. Kokudo N; Hasegawa K; Makuuchi M J Clin Oncol; 2007 Apr; 25(10):1299-300; author reply 1300. PubMed ID: 17401028 [No Abstract] [Full Text] [Related]
18. Bevacizumab improves pathologic response and protects against hepatic injury in patients treated with oxaliplatin-based chemotherapy for colorectal liver metastases. Ribero D; Wang H; Donadon M; Zorzi D; Thomas MB; Eng C; Chang DZ; Curley SA; Abdalla EK; Ellis LM; Vauthey JN Cancer; 2007 Dec; 110(12):2761-7. PubMed ID: 17960603 [TBL] [Abstract][Full Text] [Related]
19. Preoperative bevacizumab does not significantly increase postoperative complication rates in patients undergoing hepatic surgery for colorectal cancer liver metastases. Kesmodel SB; Ellis LM; Lin E; Chang GJ; Abdalla EK; Kopetz S; Vauthey JN; Rodriguez-Bigas MA; Curley SA; Feig BW J Clin Oncol; 2008 Nov; 26(32):5254-60. PubMed ID: 18854565 [TBL] [Abstract][Full Text] [Related]
20. Liver resection remains a safe procedure after neoadjuvant chemotherapy including bevacizumab: a case-controlled study. Tamandl D; Gruenberger B; Klinger M; Herberger B; Kaczirek K; Fleischmann E; Gruenberger T Ann Surg; 2010 Jul; 252(1):124-30. PubMed ID: 20562613 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]